
Hypertrophic Cardiomyopathy Lunch & Learn: Patient Access and Team-Based Care
Join us on four consequent Thursdays for a lunch and learn series on hypertrophic cardiomyopathy. This week’s sessions will cover Hypertrophic Cardiomyopathy: Patient Access and Team-Based Care led by Dr. Milind Desai, MD, MBA.
This is a 4-part lunch and learn series. You only need to register once but we hope you can join us live for all four sessions. *All sessions will be recorded and saved in your classroom if you miss a live session*
Join us on the following days:
- July 13 – Novel Treatments with Norma Flores, DNP, CRNP, AGACNP-BC, AACC, HF-Cert, CCRN
- July 20 – Patient Access and Team-Based Care with Milind Desai, MD, MBA
- July 27 – Patient Adherence with Matthew Martinez, MD, FACC and Stacey Titus, HCM Patient & Center of Excellence Coordinator
- Aug 3 – Ask the Experts, led by Jane Linderbaum, MS, ARNP, FACC, FPCNA (with guests from previous weeks)
Supported by Bristol-Myers Squibb.
Learning Objectives
July 13 – Hypertrophic Cardiomyopathy: Novel Treatments
-
- Identify characteristics of nonobstructive and obstructive HCM
- Describe the mechanism of action of cardiac myosin inhibitor
- Examine current literature and research into novel HCM treatments
- Analyze best clinical practice scenarios
July 20 – Hypertrophic Cardiomyopathy: Patient Access and Team-Based Care
-
- Discuss access considerations for novel HCM treatments
- Explain potential barriers and related solutions to prescribing a cardiac myosin inhibitor, including prior authorizations and specialty pharmacy considerations
- Compare team-based approaches for successful medication administration in clinical setting, pharmacy, and home
- List the follow-up echocardiography requirements for HCM management
July 27 – Hypertrophic Cardiomyopathy: Patient Adherence
-
- Describe the drug administration pathway from initiation to maintenance
- Discuss signs and symptoms that signify a needed dose adjustment
- Describe patient HCM treatment journey
- Assess team-based care scenarios for improving outcomes for patients taking novel medications
August 3 – Hypertrophic Cardiomyopathy: Ask the Experts
-
- Review highlights of team-based care approach to ordering and administering novel HCM pharmaceutical therapy
- Using case-based scenarios, identify best practices for prescribing and administering novel medications for HCM
- Discuss how to maximize effective communications in team-based care
- Describe effective strategies for shared decision-making for patients with HCM and their family